We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Psoriatic Arthritis Treatments in China
Price data last checked 154 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 24 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 577 days • 577 data points (No recent data available)
Price Distribution
Price distribution over 577 days • 1 price levels
Price Analysis
Most common price: £495 (577 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 577 days
Product Specifications
- Format
- paperback
- ASIN
- B0BBJRJDCT
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 24 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Psoriatic Arthritis Treatments in the United States
The 2025-2030 World Outlook for Psoriatic Arthritis Therapeutics
The 2023-2028 Outlook for Rheumatoid Arthritis Treatments in China
The 2023-2028 World Outlook for Systemic Psoriasis Therapeutics
The 2013-2018 Outlook for Psoriasis Drugs in North America & the Caribbean
The 2023-2028 Outlook for Rheumatoid Arthritis Treatments for US Zip Codes
The 2026-2031 World Outlook for Psoriasis Drugs
Psoriatic Arthritis Updates, An Issue of Rheumatic Disease Clinics of North America (Volume 51-3) (The Clinics: Internal Medicine, Volume 51-3)
Elsevier
The 2026-2031 World Outlook for Rheumatoid Arthritis Treatments
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in China
The 2025-2030 World Outlook for Psoriasis Treatments
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in Japan
The 2023 Report on Psoriasis Treatments: World Market Segmentation by City
The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs for US Zip Codes
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
The 2026-2031 World Outlook for Drugs for Rheumatoid Arthritis
The 2023 Report on Psoriasis Medicines: World Market Segmentation by City
The 2023-2028 World Outlook for Interleukin Blockers for Psoriasis Treatments
The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in China
The 2026-2031 World Outlook for Anti-Inflammatory Scleroderma Drugs
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in China
Tailored Treatments in Psoriatic Patients
IntechOpen